Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

(MedPage Today) — Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following salvage radiotherapy (sRT) informed by prostate-specific membrane antigen (PSMA) PET/CT, a retrospective…

Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/119814

Author :

Publish date : 2026-02-09 22:47:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

Simple Question May Help Identify Women With Urinary Incontinence

Is this carved rock an ancient Roman board game?

Related Posts

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

First Positive Phase 3 Drug Trial for MOGAD

SSRI Added to Antipsychotics May Raise Cardiac Risk

What NHS challenges does the election winner face?

Carotid Revascularization May Lower Seizure Risk in Stenosis

Is stem cell therapy about to transform medicine and reverse ageing?

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

First Positive Phase 3 Drug Trial for MOGAD

SSRI Added to Antipsychotics May Raise Cardiac Risk

What NHS challenges does the election winner face?

Carotid Revascularization May Lower Seizure Risk in Stenosis

Is stem cell therapy about to transform medicine and reverse ageing?

Poststroke Epilepsy Carries Higher Risk for Dementia

Assisted dying bill to run out of time as Lords hold final debate

Categories

Archives